The Essentials of Cell-Mediated Immunity Assays for the Management of CMV Infection after Solid Organ Transplantation
Year: 2025
Type: article
Abstract: Provided that cell-mediated immunity (CMI) is known to be vital in managing CMV infection post-transplant along with improving methods to predict the development of cytomegalovirus (CMV) following transplant, CMV-specific-cell-mediated immunoassays have been developed, commercially and research based, to be used in conjunction with pre-transplant CMV serological testing and prophylaxis to help tailor an individual care plan post-transplant. In this review, we assess the status of CMV CMI assays, and their potential uses in solid organ transplant recipients, including benefits and limitations.
Source: OBM Transplantation
Authors: Alexis Guenette, Valentina Stosor
Institution: Northwestern University
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4413994334
